Crisugabalin for nerve pain in NMOSD
Treatments studied
Part of Brain & nervous system, Eyes & vision, Immune system & allergy, Pain clinical trials.
This study tests an investigational drug called crisugabalin, which may help reduce nerve pain caused by NMOSD. If you join, you will receive either the drug or a placebo (a pill with no active medicine) to see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a confirmed NMOSD diagnosis and be positive for the AQP4 antibody.
- You must have nerve pain (neuropathic pain) related to your NMOSD that has been stable for at least a month.
- Your average pain score on a 0-10 scale should be at least 4.
- You must not have had severe kidney or liver problems, and must not be pregnant or planning pregnancy.
- You must not have tried certain other nerve pain medications (like high doses of pregabalin or gabapentin) without success.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called Crisugabalin to see if it helps people with nerve pain caused by radiation treatment for head and neck cancer. The study aims to find a better way to manage this type of pain that does not go away.
This trial tests a drug called glibenclamide, commonly used for diabetes, to see if it can reduce nerve pain in people with multiple sclerosis. If you join, you will receive the drug or a placebo (inactive treatment) and your pain levels will be monitored.
This trial tests an extended-release version of pregabalin (a pain medication) for people with long-term nerve pain caused by diabetes or shingles. It aims to see if this once-daily pill can reduce pain with fewer side effects.
This trial is testing two medications, pregabalin and crisugabalin, to see how safe and effective they are for people with fibromyalgia who have not yet tried prescription treatments. You may qualify if your pain is moderate to severe and nondrug approaches haven't helped enough.
This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.
This early-phase study tests B001 injection to see if it can help people with neuromyelitis optica spectrum disorder (NMOSD) who have had recent relapses. It may be aimed at reducing future attacks and improving disability over time.
Hear when a new Neuromyelitis Optica Spectrum Disorders (NMOSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.